Neidio i'r cynnwys
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Iaith
Pob Maes
Teitl
Awdur
Pwnc
Rhif Galw
ISBN/ISSN
Tag
Canfod
Uwch
Radionuclide treatment of neur...
Dyfynnu hwn
Anfonwch hwn fel neges destun
E-bostio hwn
Argraffu
Allforio Cofnod
Allforio i RefWorks
Allforio i EndNoteWeb
Allforio i EndNote
Permanent link
Radionuclide treatment of neuroendocrine tumours with the novel radiolabelled analogue Y-90-SMT 487
Manylion Llyfryddiaeth
Prif Awduron:
Carroll, P
,
Maher, K
,
Foley, R
,
Stewart, P
,
Bevan, J
,
Franklyn, J
,
Besser, G
,
Monson, J
,
Britton, K
,
Grossman, AB
Fformat:
Journal article
Cyhoeddwyd:
2003
Daliadau
Disgrifiad
Eitemau Tebyg
Dangos Staff
Eitemau Tebyg
Imaging neuroendocrine tumours with radiolabelled somatostatin analogues and X-ray computed tomography: a comparative study.
gan: King, C, et al.
Cyhoeddwyd: (1993)
Localization of neuroendocrine tumours and insulinomas using radiolabelled somatostatin analogues, 123I-Tyr3-octreotide and 111In-pentatreotide.
gan: Ur, E, et al.
Cyhoeddwyd: (1993)
Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues.
gan: Kaltsas, G, et al.
Cyhoeddwyd: (2005)
Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
gan: Kaltsas, G, et al.
Cyhoeddwyd: (2001)
The value of radiolabelled MIBG and octreotide in the diagnosis and management of neuroendocrine tumours.
gan: Kaltsas, G, et al.
Cyhoeddwyd: (2001)